Plasmapheresis in the treatment of posttransplant cardiomyopathy

Artificial Organs

Volumn 22, Issue 3, 1998, Pages 197-202

  Dzemeshkevich, S ^a,b   Ragimov, A ^a   Mikhaylov, Y ^a   Roitman, E ^a   Adrianov, S ^a   Ryikunov, I ^a   Abugov, S ^a   Sheremetyeva, G ^a   Alekseeva, L ^a   Vinnitsky, L ^a  

^a PETROVSKY NATIONAL RESEARCH CENTER OF SURGERY   (Russian Federation)

^b Department of Cardiosurgery ^*  (Russian Federation)

Author keywords

Atherosclerosis; Cardiomyopathy; Plasmapheresis

Indexed keywords

ELASTICITY; HEART; NUCLEAR MEDICINE;

ACUTE REJECTION; BLOOD RHEOLOGY; CARDIOMYOPATHY; CORONARY ARTERIES; CORONARY PERFUSION; HEART FAILURE; HEART TRANSPLANTATION; MYOCARDIAL FUNCTION; NUMBER OF FACTORS; PLASMAPHERESIS;

DISEASES;

ACETYLSALICYLIC ACID; ALBUMIN; ATENOLOL; AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN A; DEXTRAN; ETAMSYLATE; LIPOPROTEIN; LOW MOLECULAR WEIGHT HEPARIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MEVINOLIN; NADROPARIN; NIFEDIPINE; PENTOXIFYLLINE; PREDNISOLONE; PROPRANOLOL; TOCOPHEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD RHEOLOGY; CARDIOMYOPATHY; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HEART TRANSPLANTATION; HUMAN; HYPERLIPOPROTEINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MACHINE; MALE; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

CYTOMEGALOVIRUS;

EID: 15444341545     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1998.06003.x     Document Type: Article

References (14)

1. Hosenpud JD, Novick RJ, Breen TJ, Keck B, Daily P. The registry of the International Society for Heart and Lung Transplantation: Twelfth official report - 1995. J Heart Lung Transplant 1995;14(5):805-15.
2. Sharples LD, Caine N, Mullins P, Scott J, Solis E, English T, Large S, Schofield P, Wallwork J. Risk factor analysis for the major hazards following heart transplantation - rejection, infection, and coronary occlusive disease. Transplantation 1991;52(2):244-52.
3. Gao S-Z, Hunt Sh, Schroeder J. Accelerated graft coronary artery disease. Thorac Transplant 1995;273-89.
4. Billingham M, Berry G. The pathology of cardiac transplantation. In: Shumway S, Shumway N, eds. Thoracic Transplantology. Boston: Blackwell Science, 1995:309-330.
5. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
6. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488-500.
7. Schwartz C, Valente A, Sprague E. A modern view of atherogenesis. Am J Cardiol 1993;71:9B-14B.
8. Friedewald W, Levy R, Fredrickson D. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem 1974;18(3):499-502.
9. Lee K, Pierce J, Hess M, Hastillo A, Wechsler A, Guerraty A. Cardiac transplantation with corticosteroid - free immunosuppression: Long-term results. Ann Thorac Surg 1991;52: 211-8.
10. Stamler J, Vaugham D, Loscalzo J. Immunosuppressive therapy and lipoprotein abnormalities after cardiac transplantation. Am J Cardiol 1991;68:389-91.
11. Waser M, Maggiorini M, Binswanger U, Kensch G, Carrel T, von Segesser L, Gallino A, Turina M. Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients. J Heart Lung Transplant 1993;12:846-50.
12. Hammond E, Yowell R, Nunoda S, Menlove R, Renlund D. Vascular (humoral) resection heart transplantation: Pathologic observations and clinical implications. J Heart Transplant 1989;6:430-43.
13. Thomson J. Production of severe atheroma in a transplanted human heart. Lancet 1969;2:1088-92.
14. Peters J, Kubo S, Olivari M, Knutson K, Hunninghake D. Treatment of hyperlipidemia in heart transplant recipients with gemfibrozil + lovastatin. Am J Cardiol 1993;71:1485-8.